ASXL1 and myeloproliferative neoplasm: Recent study demonstrated that men have a higher mutational burden in CD34-positive cells and higher risk of non-MPN-specific high-risk mutations including in ASXL1, EZH2, SRSF2, U2AF1, and IDH1/2 genes compared with women [25].